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Abstract
Positron emission tomography (PET) has come to play an increasingly important role in the
evaluation of pulmonary lesions, which are suspicious of malignancy. As is true for other techniques,
PET gives false positive and negative results. We report a case of pulmonary amyloidosis with
multiple pulmonary nodules showing different uptake of 18 F-fluorodeoxyglucose (FDG) on PET.
There are limitations of specificity of FDG-PET in characterising pulmonary nodules and it is
important to confirm a suspected malignancy with histology before potentially curative treatment
is undertaken.
Background
PET imaging is a technology that is used to identify focal
areas of increased cellular metabolism. FDG is an excel-
lent tracer for detecting malignant disease because of high
glucose metabolism observed in cancer cells. With this
technique whole body image can be created to accurately
identify malignant primary neoplasm and metastatic dis-
ease.
For pulmonary lesions FDG-PET has been used to differ-
entiate malignant from benign lesions and to stage and
follow patients with lung cancer. PET has demonstrated
sensitivity and specificity rates of 80–90% compared to
50–60% for CT [1]. Low-grade malignant lesions such as
carcinoids and localised broncho-alveolar carcinomas
have shown low to intermediate glucose metabolism and
negative PET images [2]. On other hand, there have been
reports of false positive PET in metabolically active benign
lesions like tuberculous granulomas, coccidiomycosis and
aspergillosis [3,5]. There have been anecdotal case reports
of false positive PET in pulmonary amyloidosis [5,6].
Amyloidosis is a disorder in which insoluble protein
fibres become deposited in tissues and organs. The exact
mechanism that causes amyloidosis is unknown. How-
ever, primary amyloidosis appears to be related to abnor-
mal production of amino globulins by plasma cells
whereas secondary amyloidosis is associated with the
presence of chronic inflammation of infectious disease. A
variety of inflammatory and infectious disorders can
result in increased FDG activity. Gallium 67, an inflam-
matory seeking agent, has been reported to have shown
intense uptake in amyloid goitre as a result of inflamma-
tory action. It is conceivable that inflammatory action
caused by amyloid lesion result in increased FDG
uptake[7]. What makes our case interesting is the fact that
in the same patient different amyloid nodules had differ-
ent uptake of FDG on PET.
Case report
A 55-year-old farmer was referred to our hospital for fur-
ther evaluation of multiple pulmonary nodules detected
on his chest x-ray for his chronic cough. He was a smoker
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with a history of asbestos exposure. His physical examina-
tion and laboratory findings were unremarkable. A com-
puted tomography (CT) scan of the chest revealed
multiple bilateral focal pulmonary lesions varying in size
from 1 to 2.5 cm with no evidence of lymphadenopathy.
The largest nodule measuring 2.5 × 2.5-cm was noticed in
the apical segment of the left lower lobe (Figure 1, top
panel). CT findings were suspicious of multiple pulmo-
nary metastasis. He had FNA of one of the peripheral nod-
ules on the left side under CT guidance and the
microscopy was suggestive of nodular amyloidosis. To
rule out malignancy in the rest of the nodules he under-
went an FDG-PET scan (Figure 2). On PET scan there was
intense focal uptake in the left lower lobe which corre-
sponded with the dominant pulmonary nodule on CT
scan and the degree of activity was highly suspicious of
neoplastic origin (Figure 1, bottom panel). There was no
other metabolically active lesion seen in the lungs that
would correspond with the nodular opacities identified
on CT. Though some of the nodules were below the size
resolution of PET and remained uncharacterised, how-
ever, others were large and in the absence of significant
uptake these were thought to be benign on PET scan.
Given the dangers of reporting benign disease on FNA, it
was thought prudent to confirm the diagnosis with exci-
sion biopsy. Surgical exploration revealed a well-demar-
cated palpable mass in the apical segment of the left lower
lobe. There was another smaller nodule present in the left
upper lobe. Both of these were wedged out and sent for
frozen section. The histopathology findings were consist-
ent with pulmonary amyloidosis in both the nodules.
Afterwards, the patient was investigated for evidence of
myeloma or plasmacytoma. All subsequent investigations
including bone scan, bone marrow aspiration trephine
were normal and ruled out secondary amyloidosis.
Conclusion
This case emphasises the limitations of specificity of FDG-
PET in characterising pulmonary nodules and the impor-
tance of confirming suspected malignancy with histology
before potentially curative treatment is undertaken. Fur-
ther studies for mechanism of such false positive results
on PET scan are warranted.
Top panel: Computed tomography scan showing multiple  rounded nodules in the right and left lung fields Figure 1
Top panel: Computed tomography scan showing multiple 
rounded nodules in the right and left lung fields. Middle panel: 
Corresponding sections on PET scan. Bottom panel: Superim-
position of PET scan on CT scan shows that the intense 
uptake on PET scan corresponds to the lesion in the left 
lower lobe on CT scan. The rest of the lesions in lung fields 
do not show any uptake on PET scan.
PET scan demonstrating a focus of intense FDG activity  (arrow mark) in the left lung field Figure 2
PET scan demonstrating a focus of intense FDG activity 
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